The best healthcare denial management software for hospitals

Claim denials now consume up to 5% of net patient revenue when they are left unmanaged. Industry-wide denial rates hit 11.65% in 2025, with some specialty environments exceeding 20%.

For most hospital billing a denial management platform that fits the size, payer mix, and workflow of their organization would be the perfect solution.

This guide covers the leading options in 2026, both AI-native and traditional, what each one does well, and where Aegis Health fits within that landscape.

Key takeaways

• Denial rates hit 11.65% industry-wide in 2025, with up to 60% of denied claims never appealed, per HFMA.
• Enterprise platforms like Waystar and FinThrive suit large health systems with complex multi-payer environments but carry 6-12 month implementation timelines.
• AI-native platforms like Aegis Health deliver faster time-to-value with automated appeal generation, payer-specific logic, and real-time submission.
• The key distinction in 2026 is between platforms that surface denials and platforms that actually work them autonomously.
• Smaller practices and mid-size hospitals tend to get stronger ROI from focused AI platforms than from large RCM suites.

How denial management software has changed in 2026

Payers have quietly become more aggressive. Prior authorization requirements keep expanding, appeal windows are getting shorter, and clinical denial criteria are applied more precisely than they were three years ago.

The software market has responded. Platforms that once just flagged denials now increasingly classify them, build appeal packets, submit directly to payer portals, and track resolution - staff members don’t need to manage each step manually. The shift from "visibility tool" to "autonomous resolution platform" is the most important difference to understand when evaluating options today.

Good denial management healthcare software does three things:

• It prevents denials through pre-submission scrubbing
• It prioritizes the ones that do come back by value and overturn likelihood
• It automates the appeal workflow so fewer claims get abandoned before the filing deadline.

Most platforms claim all three. But not all deliver on each one, which is why understanding where an option is actually strongest matters more than reading a feature list.

For a grounding in what a complete denial management workflow looks like end to end, our guide to healthcare claims denial management covers the full cycle from intake to appeal resolution in practical detail.

Enterprise platforms for healthcare denial management: Waystar and FinThrive

Waystar is the most widely deployed RCM platform in the US, processing roughly $1.8 trillion in claims annually and touching close to half the patient population. Its denial module uses predictive analytics trained on billions of historical transactions to score denials by overturn probability and revenue at stake, so billing teams work the highest-value cases first. Its AltitudeAI feature accelerates appeal packet generation.

Waystar won Best in KLAS for Claims Management and Clearinghouse in 2025 with a score of 91.8, per Waystar's own KLAS announcement, marking over a dozen consecutive years at the top of that category.

The tradeoff is scale and complexity. Waystar is built for large organizations already running its broader RCM suite. Implementation timelines typically run six to twelve months, and the platform's depth can be more than a mid-size hospital needs or can support, according to MD Clarity's 2026 denial software comparison.

FinThrive takes a similar enterprise approach with its Denials and Underpayment Analyzer, which uses daily-refreshed line-level data and natural language querying so billing staff can interrogate denial trends without exporting to a spreadsheet. Customer-reported results from HIMSS 2026 showed a 2.5% reduction in denial rates and close to $1 million in additional cash within three months at one health system. FinThrive's strength is orchestration across 50-plus AI and automation use cases, but like Waystar, it's positioned for large multi-facility systems, not practices looking for a focused denial tool with a short ramp.

Payer-connectivity platforms compared: Availity and Experian Health

Availity operates one of the largest health information networks in the US and launched an AI-powered prior authorization experience with Abridge in January 2026. Its denial management tooling is built primarily around payer connectivity. Strong on real-time claim visibility, lighter on autonomous workflow automation.

Experian Health has won Best in KLAS for contract management three years running and integrates denial prevention tightly with patient access and eligibility verification. OrthoTennessee achieved an 86% appeal success rate using Experian's tools. For hospitals already using Experian's patient access products, the integration makes adding denial management straightforward.

Both platforms suit organizations where payer connectivity and eligibility accuracy are the primary problem, not appeal volume or autonomous claim resolution. Hospital denial management software for teams whose biggest pain point is a large appeal queue and insufficient staff bandwidth to work it tends to need more than what either of these platforms prioritizes.

Specialty and mid-market software for hospitals

Aspirion focuses on complex, high-value denials in clinical specialties like oncology and cardiology, where denial rates run highest and the documentation requirements are most demanding. It's a strong fit for specialty hospitals where clinical nuance drives most of the denial volume.

Innovaccer's Flow earned top recognition across 18 KPIs in Black Book's 2026 AI-Powered Revenue Cycle Autonomy evaluation and is already deployed at Kaiser Permanente, Ascension, and Trinity Health. Its strength is in data quality, pulling clinical evidence directly from medical records to generate payer-specific appeal packets in minutes.

For smaller practices, AdvancedMD and Tebra both include denial management within their broader EHR and billing platforms, without requiring a separate RCM implementation. Neither matches the AI depth of purpose-built denial platforms, but they work well for low-volume environments where simplicity and cost matter more than automation sophistication.

How do AI-native denial platforms work?

The split in 2026 is between platforms that show you your denials and platforms that work them.

Most traditional RCM tools surface denial data in a dashboard and leave the resolution work to staff. AI-native platforms go further: they classify the denial, pull supporting documentation, generate payer-specific appeal letters, and submit them directly to payer portals pending human review. The labor that a billing specialist used to spend 30 to 90 minutes on per claim gets compressed to a staff member reviewing and approving a packet the system already built.

Medical necessity denials are where this distinction matters most. Payer-specific clinical framing, policy citations, and documentation precision are what determine overturn rates on complex appeals, and getting those details right consistently across hundreds of claims per month is where manual workflows break down fastest. Our breakdown of AI platforms for medical necessity appeals explains how AI handles the clinical documentation requirements for these specifically.

How does Aegis Health compare to other denial management solutions?

Aegis is built specifically around the denial management problem rather than as a module inside a broader RCM suite. That distinction matters in practice.

The platform classifies incoming denials automatically, scores them by dollar value and overturn likelihood, and generates payer-specific appeal letters using EHR and EOB data. Staff review and approve the packet before it goes out. Submission goes directly to payer portals with automated status tracking until resolution. The full cycle, from denial flagged to appeal queued for review, runs in minutes rather than the 30 to 90 minutes a manual workflow requires.

The best AI denial management software for clinics in 2026 means something different depending on whether you need an enterprise suite or a focused tool. Aegis is purpose-built for the latter: hospitals and growing health systems that need AI-driven denial resolution without a six-month implementation project before anything goes live. Implementation is measured in weeks, not quarters.

Aegis also prioritizes the highest-value denials automatically. Teams aren't working the queue in the order claims arrived. They're working the cases with the highest dollar value and the strongest overturn probability first, which changes both recovery rates and the way billing managers allocate staff time.

How to choose the right platform for your hospital

Three questions cut through most of the comparison work.

First, what's your primary denial problem? Front-end eligibility errors point toward Experian Health or Availity. High-volume appeal backlogs point toward an AI-native platform like Aegis. Complex clinical denials in specialty environments point toward Aspirion or Innovaccer.

Second, what's your organization's size and IT capacity? Enterprise platforms like Waystar and FinThrive are powerful but require significant implementation resources. Choosing the right denial management solution for a mid-size hospital often means prioritizing time-to-value over feature breadth.

Third, do you need a full RCM suite or a focused denial tool? If denial management is your specific gap and your existing billing platform handles everything else adequately, adding a full RCM suite creates more complexity than it solves. A purpose-built platform that plugs into your existing EHR and payer portals is usually the faster, cleaner path.

What results should you expect once the denial management software is running?

Set your baseline before deployment. Denial rate by payer, days in AR, cost per denial worked, and appeal overturn rate are the four numbers that tell you whether the platform is performing.

Most AI-driven platforms show measurable movement in appeal turnaround time and first-pass resolution rate within the first two quarters. Organizations using AI-driven denial management solution tools report denial rate reductions of 10 to 25% within six months, with appeal overturn rates improving as submissions go out faster and with more complete documentation.

For the broader cost picture, 5 ways hospitals use AI to cut operating costs covers where denial management fits within a wider financial strategy, including how it compounds with other AI investments already running in the revenue cycle.

The right denial management software matches your denial profile

There's no single best platform for every hospital. Waystar and FinThrive are strong for large systems that need enterprise-grade RCM infrastructure. Experian Health and Availity suit organizations where payer connectivity is the primary gap. Aspirion and Innovaccer excel in specialty and data-heavy environments.

For hospitals that need AI-driven denial resolution without enterprise complexity, AI in healthcare platforms like Aegis Health are built to deliver results in weeks rather than quarters, with automated appeal generation, real-time payer submission, and prioritization logic that puts the highest-value work in front of your team first.

If you want to see how it handles your specific denial mix, book a free demo with our experts at Aegis Health and we'll be happy to walk through your data with you.